Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus

International Journal of Rheumatic Diseases

Volumn 12, Issue 2, 2009, Pages 100-106

  Suleiman, Suleima ^a   Kamaliah, Daud ^b   Nadeem, Afzal ^a   Naing, Nyi Nyi ^a   Che Maraina, Che Hussin ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Anti nucleosome antibodies; Disease activity marker; SLE

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEOSOMES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67749145535     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01391.x     Document Type: Article

References (28)

1. Hochberg MC (1997) Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus Erythematosus [letter]. Arthritis Rheum 40, 1725.
2. Amoura Z, Piette JC, Bach JF, Koutouzov S (1999) The key role of nucleosome in lupus. Arthritis Rheum 42, 833-43.
3. Pisetsky DS (2000) Anti-DNA and autoantibodies. Curr Opin Rheumatol 12, 364-8.
4. Ghillani-Dalbin P, Amoura Z, Cacoub P, et al. (2003) Testing for anti-nucleosome antibodies in daily practice: A monocentric evaluation in 1696 patients. Lupus 12, 833-7.
5. Amoura Z, Chabre H, Koutouzov S, et al. (1994) Nucleosome-restricted antibodies are detected before anti-DNA and/or anti-histone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice and sre present in kidney elutes of lupus mice with protenuria. Arthritis Rheum 37, 1684-8.
6. Kramers C, Hylkema MN, Van Bruggen MC, et al. (1994) Anti-nucleosome antibodies complexes to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94, 568-77.
7. Amoura Z, Koutouzov S, Piette JC (2000) The role of nucleosomes in lupus. Curr Opin Rheumatol 12, 369-73.
8. Burlingame W (2004) Recent advances in understanding the clinical utility and underlying cause of anti-nucleososme autoantibodies. Clin Appl Immunol Rev 4, 351-66.
9. Bombardier C, Gladman DD, Urowitz MB, caron D, Chang CH (1992) The development and validation of the SLE Disease Activity Index (SLEDAI). Arthritis Rheum 35, 630-40.
10. Petri M (1998) Treatment of systemic lupus erythematosus: An update>. Am Fam Physician 57, 2753-60.
11. Molina JF, McGrath H (1997) Long term ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 24, 1072-4.
12. Bellomio V, Spindler A, Lucero E, Berman A, Santana M, Moreno C (2000) Systemic Lupus erythematosus: Mortality and survival in Argentina. A multicenter study. Lupus 4, 370-4.
13. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F (2000) Nucleosome are major T and B cells autoantigens in systemic lupus erythematosus. Arthritis Rheum 43, 2307-15.
14. Carins AP, McMillan SA, Crockard AD, Meenagh GK, Bell AL, Armgstrong DJ (2003) Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 62, 272-3.
15. Quattroccchi P, Barrile A, Bonnano D, et al. (2005) The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases. Rheumatismo 57, 109-13.
16. Hmida Y, Sohmit P, Glison G, Humbel RL (2002) Failure to detect antinucleosome antibodies in scleroderma: Comment on the article by Amoura et al. Arthritis Rheum 46, 280-2.
17. Ghirardello A, Doria A, Zampieri S et al. (2004) Anti-nucleosome antibodies in SLE: A two-year follow-up study of 101 patients. J Autoimmunity 22, 235-40.
18. Preud'homme JI, Rochard E, Gout D (1998) Isotypic distribution of anti-dsDNA antibodies: A diagnostic evaluation by ELISA. Diagn Clin Immunol 5, 256-61.
19. Albani S, Massa M, Vioila S (1990) Antibody reactivity against single stranded DNA of various species in normal children and in children with diffuse connective tissue diseases. Autoimmunity 8, 77-80.
20. Avina-Zubieta JA, Galindo-Rodriguez G, Kwan-Yeung C (1995) Clinical evaluation of various selected ELISA kits for the detection of anti-dsDNA antibodies. Lupus 4, 370-81.
21. Raz E, Brezis M, Rosenmann E, Eliat D (1989) Anti-dsDNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 142, 3076-82.
22. Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G (1999) DNA level in circulating immune complexes decrease at severe SLE flares: Correlation with complement component C1q. J Autoimmune 13, 111-9.
23. Horak P, Scudla V, Hermanova Z et al. (1994) Clinical utility of selected disease activity markers in patients with systemic lupus eythematosus. Clin Rheumatol 20, 337-44.
24. Benucci M, Gobbi F, Rosso A, Cesaretti S, Niccoli L (1999) Disease activity and anti-nucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 32, 42-5.
25. Horak P, Hermanova Z, Scudla V, Faltynek L, Pospisil Z (2000) Anti-nucleosome antibodies: A novel test in systemic lupus erythematosus. Acta University Palaki Olomuc Fac Med 144, 27-32.
26. Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J (2004) Anti-nucleosome antibodies in patients with SLE of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatol 43, 220-4.
27. Haddouk S, Ben Ayed M, baklouti S, Hachicha J, Bahloul Z, Masmoudi H (2005) Clinical significance of anti-nucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 24, 219-22.
28. Amoura Z, Piette JC, Chabre H (1997) Circulating plasma level nucleosome in patients with SLE. Correlation antinucleosome antibody titer and absence of clear association with disease activity. Arthritis Rheum 40, 2217-25.